Clinical Trial Update: A Trial Investigating the NN1250 Concentration-time Curve in Subjects With Various Degrees of Renal Impairment and in Subjects With Normal Renal Function [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated the concentration-time profile of NN1250 in subjects with varying degrees of renal impairment and in healthy volunteers, including …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• NN1250

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Healthy | Phase 1 | Status: COMPLETED